Imaging3 files for Chapter 11; Given Imaging seeks PillCam approval in Japan;

 @FierceMedDev: Japan's Olympus (makes med equipment/cameras) may be very close to getting a huge investment from Sony. WSJ reports. More | Follow @FierceMedDev

 @MarkHFierce: The U.S.'s othopedic soft tissue device market should grow to $2 billion by 2016, Millennium Research Group believes. More | Follow @MarkHFierce

 @DamianFierce: Torax Medical snagged $30M in VC funding to market its anti-acid reflux device. Story | Follow @DamianFierce

> Imaging3, a maker of 3D medical diagnostic imaging devices, is filing for Chapter 11 bankruptcy. News

> Healthsense, a startup developing wireless remote monitoring devices for seniors, pulled in a $7 million Series D round. Report

> Given Imaging ($GIVN) will pursue Japanese regulatory approval for its PillCam Colon 2, a video capsule that patients swallow in order to capture endoscopic images. Release

> As the medical device world prepares for January's 2.3% excise tax on U.S. sales, many companies are scrambling to figure out how the charge will affect their products. Item

> Illumina ($ILMN) is buying the U.K.'s BlueGnome, maker of in vitro diagnostics, for an undisclosed sum. More

> IntelliRad Control is developing a device to reduce the amount of radiation patients are exposed to in diagnostic procedures, and the company raised $5.3 million venture financing. Article

> Thermo Fisher Scientific ($TMO) has opened an R&D center in Vilnius, Lithuania, looking to develop new diagnostic assays and expand its sales in Eastern Europe. Release

> Utah's Concept to Company is offering $45,000 to medical device entrepreneurs with fresh ideas through its medical innovation contest. Story

Biotech News

 @FierceBiotech: fuels biotech's hunt for flu therapies. Story | Follow @FierceBiotech

 @JohnCFierce: The Fierce 15: An appetite for risk is healthy in drug development. Report | Follow @JohnCFierce

 @RyanMFierce: 10 pharma giants form nonprofit to gang up on common R&D foes. More | Follow @RyanMFierce

> Baxter and Onconova ink $500M-plus licensing pact for PhIII cancer drug. News

> After FDA blessings for diet drugs, spotlight shines on biotechs' pioneering obesity meds. More

> Wellington Partners rounds up $91M for new European life sciences fund. Article

Pharma News

 @FiercePharma: Working Mother's Top 100 employers list includes 10 drugmakers. Discrimination lawsuits (for some) notwithstanding. More | Follow @FiercePharma

> Lundbeck to stop making cancer drug. Story

> Lawyers seek to force J&J chief onto the stand in Risperdal case. News

> Pfizer faces class action claiming Wyeth misled investors on Pristiq. More

Drug Delivery News

> Fast migraine treatment battles sickness, too. Story

> BDSI's addiction oral patch approaches the market. Article

> Origami DNA may take twist out of doxorubicin delivery. News

> Ultrasound gets drugs right under the skin. More

Biomarkers News

> Genetic biomarkers and the frets of the 'worried well'. More

> Gene mutations point to personalized therapy in lung cancer. Story

> Breath biomarkers could breathe life into lung cancer tests. Article

> BRCA mutations may pinpoint response to Abbott's veliparib. News

Suggested Articles

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.

CMR Surgical will have a new CEO at the top of the year, as it kicks off the global launch of its modular Versius system while awaiting FDA approval.

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.